RBC Capital reiterated coverage of Centamin with a rating of Sector Perform and set a new price target of $115.00 from $128.00 previously
Save time and jump to the most important pieces.
RBC Capital reiterated coverage of Centamin with a rating of Sector Perform and set a new price target of $115.00 from $128.00 previously
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund"). As previously reported, certain of the Fund's Russian holdings have been valued at zero since March 14, 2022 in light of measures adopted by the Russian Central Bank and Government, as well as sanctions implemented by the United States and other countries in response to Russia's invasion of Ukraine. The effects of the sanctions and measures adopted by the Russian Central Bank and Government are far-reaching and include, among others, the freezing of certain Russian assets held by entities, such as the Fund, that are organized in countries viewed as "unfriendly" by the Russian Government. The Fund's investment manager has b
The Central and Eastern Europe Fund, Inc. (NYSE:CEE) (the "Fund"). As previously reported, certain of the Fund's Russian holdings have been valued at zero since March 14, 2022 in light of measures adopted by the Russian Central Bank and Government, as well as sanctions implemented by the United States and other countries in response to Russia's invasion of Ukraine. The effects of the sanctions and measures adopted by the Russian Central Bank and Government are far-reaching and include, among others, the freezing of certain Russian assets held by entities, such as the Fund, that are organized in countries viewed as "unfriendly" by the Russian Government. The Fund's investment manager has be
The Central and Eastern Europe Fund, Inc. (NYSE:CEE), The European Equity Fund, Inc. (NYSE:EEA), and The New Germany Fund, Inc. (NYSE:GF) (each, a "Fund," and collectively, the "Funds") each announced today that its Board of Directors has approved an extension of the current repurchase authorization permitting open market share repurchase program for an additional twelve-month period. Each Fund may continue to purchase outstanding shares of its common stock in open-market transactions over the twelve-month period from August 1, 2024 through July 31, 2025 when the Fund's shares trade at a discount to net asset value ("NAV") and such purchases are deemed to be in the best interests of the Fun
3 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
SC 13G/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Subject)
N-PX - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
N-CSRS - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
DEFA14A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Filer)
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. • InflaRx (NASDAQ:IFRX) is projected to report quarterly loss at $0.20 per share on revenue of $1.42 million. • Fennec Pharmaceuticals (NASDAQ:FENC) is likely to report quarterly loss at $0.02 per share on revenue of $8.67 million. • Welltower (NYSE:WELL) is likely to report quarterly earnings at $0.00 per share on revenue of $218.97 million. • VerifyMe (NASDAQ:VRME) is expected to report quarterly loss at $0.03 per share on revenue of $8.95 million. • Academy Sports (NASDAQ:ASO) is expected to report quarterly earnings at $2.2
Endeavour Mining (LSE: EDV) announced the abrupt termination of CEO Sébastien de Montessus, citing "serious misconduct" and irregularities linked to the sale of a company asset. Following the news, shares dropped by 14% before erasing some losses during the Friday session. Endeavour is a constituent of the FTSE 100 Index while also listed on the Toronto Stock Exchange. According to a statement, the London-based company took decisive action after uncovering an alleged “irregular payment instruction” amounting to $5.9 million related to an asset sale. Additionally, an external investigation into de Montessus’s conduct with colleagues, prompted by allegations from October, led to
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. • ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to report quarterly loss at $0.17 per share on revenue of $3.96 million. • Blue Apron Hldgs (NYSE:APRN) is expected to report quarterly loss at $0.83 per share on revenue of $100.13 million. • Yiren Digital (NYSE:YRD) is estimated to report earnings for its second quarter. • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.08 per share on revenue of $2.29 billion. • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.29 per share on revenue
4/A - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)
4 - CENTRAL & EASTERN EUROPE FUND, INC. (0000860489) (Issuer)